The cervix is the lower part of the uterus that connects to the vagina. Cervical cancer develops in the cells of the cervix. Strains of Human Papillomavirus (HPV), a sexually transmitted infection, play a role in causing most of the cervical cancers. The disease begins when healthy cells acquire mutation leading to the uncontrolled growth of cells. These cells form a tumour which invades the nearby tissues. Squamous cell carcinomas, adenocarcinomas, and adenosquamous carcinomas are three types of cervical cancers. Squamous cell carcinomas develop from cells in the exo-cervix while adenocarcinomas develop from gland cells. The cancer cells are said to have features of squamous cells under the microscope. Adenosquamous carcinomas feature both squamous cell carcinomas and adenocarcinomas. Cryosurgery, laser surgery, simple hysterectomy, radical hysterectomy, and trachelectomy are various treatment options for cervical cancer. Cystoscopy, proctoscopy, examination under anaesthesia, and imaging studies such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), intravenous urography, and Positron Emission Tomography (PET scan) are used of the diagnosis of cervical cancer.
The cervical cancer treatment market is mainly driven by the increasing prevalence of cervical cancer and increasing awareness about cervical cancer among women. Furthermore, the increasing demand for early diagnosis and treatment of cervical cancer is also expected to fuel the growth of the market during the review period. However, the high cost of treatment also fuels the growth of the market. The World Health Organization (WHO) stated that cancer was the leading cause of the total number of deaths globally in 2015 and was responsible for 8.8 million deaths.
For request sample: https://precisionbusinessinsights.com/request-sample/?product_id=23732
Cervical Cancer Treatment Market was valued at US$ XX Mn in 201X and expected to grow at X% Compound Annual Growth Rate (CAGR) over 201X to 202X
Cervical cancer is characterized by the growth of abnormal cells in the cervix region. It is most commonly occurred in women due to Human Papilloma Virus (HPV) infection. Most common symptoms associated with cervical cancer include pelvic pain, vaginal bleeding, abnormal vaginal discharge, and pain during the sexual intercourse. Cervical cancer can be treated by chemotherapy, radiation therapy, and surgery among others.
Competition Assessment: Cervical Cancer Treatment Market
Some of the players in the global cervical cancer treatment market include:
• GlaxoSmithKline Plc (UK)
• Allergan Plc (UK)
• Eli Lilly and Company (U.S.)
• Pfizer, Inc. (U.S.)
• Bristol-Myers Squibb Company (U.S.)
• Genentech USA (U.S.)
• Novartis AG (Switzerland)
• Hoffmann La Roche Ltd (Switzerland)
• Biocon Ltd. (India)
• Hetero Drugs Ltd. (India)
Precision Business Insights (PBI) in its report titled “Cervical Cancer Treatment Market”: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 20XX-20XX and Forecast 20XX-20XX” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast.
Market Scope: Cervical Cancer Treatment Market
Cervical cancer treatment market is segmented based on the disease indication, treatment type, and end user
Based on the disease indication, the market is segmented into the following:
• Pre-malignant Lesions
• Early Invasive Stage
• Advanced Invasive Stage
Based on the treatment type, the market is segmented into the following:
• Simple Hysterectomy
• Radical Trachelectomy
• Cryotherapy
• Laser Surgery
• Cold Knife Cone Biopsy
• Cone Biopsy
• LEEP (Loop Electrosurgical Exclusion Procedure)
• Chemotherapy
• Hormone Therapy
• Radiation Therapy
• Targeted Therapy
• Others
Based on the end user, the market is segmented into the following:
• Hospitals
• Ambulatory Surgical Centres
• Pharmacies
For more information:https://precisionbusinessinsights.com/market-reports/cervical-cancer-treatment-market/